Phase I of XKH002 Injection in Patients

Clinical trial NCT06196762 · UNKNOWN

Trial details

NCT number: NCT06196762
Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors

Start date: 2023-11-27
Primary completion: 2025-12-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.